Treatment of spontaneous panic attacks with chlomipramine
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Recurrent spontaneous panic attacks are psychophysiological symptoms present in panic disorder and agoraphobia with panic attacks. Effective pharmacological treatment for panic attacks is essential to any treatment plan for these conditions. The authors administered chlomipramine to 20 patients who had panic disorder or agoraphobia with panic attacks, and after 8 weeks of treatment 75% of the patients with each diagnosis were asymptomatic. These results support the claim that chlomipramine is highly effective in preventing recurrence of panic attacks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delineation of two drug-responsive anxiety syndromes
Klein, D. F. (1964) · Psychopharmacologia · doi:10.1007/bf02193476 · Cited by 898
Cited by
Reconciling the role of central serotonin neurons in human and animal behavior
Soubrié, P. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00022871 · Cited by 996
Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987) · Psychopharmacology · doi:10.1007/bf00215473 · Cited by 462
A neuroanatomical hypothesis for panic disorder
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.148 · Cited by 409
The elevated T-maze as an experimental model of anxiety
Graeff, F. G., Ferreira Netto, C., & Zangrossi Jr, H. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00024-4 · Cited by 391
Can interoception improve the pragmatic search for biomarkers in psychiatry?
Khalsa, S. S., & Lapidus, R. C. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00121 · Cited by 366
Response to hyperventilation in a group of patients with panic disorder
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.857 · Cited by 354
Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00210-8 · Cited by 196
McTavish, D., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199039010-00010 · Cited by 161
Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder
Lecrubier, Y., Judge, R., & The Collaborative Paroxetine Panic Study Investigators (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00389.x · Cited by 139
Allen, D., Curran, H. V., & Lader, M. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00265843 · Cited by 51
A dose-finding and discontinuation study of clomipramine in panic disorder
Lotufo-Neto, F., Bernik, M., Ramos, R. T., Andrade, L., Gorenstein, C., Cordás, T., Melo, M., & Gentil, V. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500103 · Cited by 27
“Although many patients respond to clomipramine in doses as low as 50 mg/day (Gloger et al., 1981, 1989; Gentil, 1986), the dose-range and time length required to achieve operationally defined full remission remain to be established.”
BackgroundCassano, G. B., Toni, C., Petracca, A., Deltito, J., Benkert, O., Curtis, G., Hippius, H., Maier, W., Shera, D., & Klerman, G. (1994) · European Neuropsychopharmacology · doi:10.1016/0924-977x(94)90314-x · Cited by 23
“…et al., 1980; Mavissakalian et al., 1986; Schweizer et al., 1993) and of other drugs such as phenelzine (Sheehan et al., 1984), clomipramine (Gloger et al., 1981, Grunhaus et al., 1984; Cassano et al., 1988), alprazolam (Chouinard et al., 1983: Sheehan et al., 1984; Charney et al., 1986),…”
Background
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1981-09-01
- Volume
- 138
- Issue
- 9
- Pages
- 1215-1217
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2397750522
- Cited by
- 115
- References
- 1
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.